Modelling factors associated with therapeutic inertia in hypertensive patients: Analysis using repeated data from a hospital registry in West Africa

• Published in: Medicine (Baltimore) Vol. 101; no. 49; p. e31147
• Main Authors: Barro, Mahamadou, Yaméogo, Aristide Relwendé, Mba, Robert Darlin, Kaboré, Rémi, Mandi, Germain, Dahourou, Désiré Lucien, Zabsonré, Patrice, Méda, Nicolas, Goungounga, Juste
• Format: Journal Article
• Language: English
• Published: United States Lippincott, Williams & Wilkins 09.12.2022; Lippincott Williams & Wilkins
• Subjects: Africa, Western; Antihypertensive Agents - pharmacology; Antihypertensive Agents - therapeutic use; Blood Pressure; Female; Humans; Hypertension - drug therapy; Life Sciences; Male; Middle Aged; Observational Study; Registries; Retrospective Studies; Santé publique et épidémiologie; Africa, Western; Hypertension; Therapeutic inertia; Heterogeneity; Determinants; Blood pressure variability
• ISSN: 1536-5964; 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000031147

The proportion of poorly controlled hypertensives still remains high in the general African population. This is largely due to therapeutic inertia (TI), defined as the failure to intensify or modify treatment in a patient with poorly controlled blood pressure (BP). The objective of this study was to identify the determinants of TI. We conducted a retrospective cohort study from March 2012 to February 2014 of hypertensive patients followed during 4 medical visits. The TI score was the number of visits with TI divided by the number of visits where a therapeutic change was indicated. A random-effects logistic model was used to identify the determinants of TI. A total of 200 subjects were included, with a mean age of 57.98 years and 67% men. The TI score was measured at 85.57% (confidence interval [CI] 95% = [82.41-88.92]). Measured individual heterogeneity was significantly significant (0.78). Three factors were associated with treatment inertia, namely the number of antihypertensive drugs (odd ratios [OR] = 1.27; CI = [1.02-1.58]), the time between consultations (OR = 0.94; CI = [0.91-0.97]), and treatment noncompliance (OR = 15.18; CI = [3.13-73.70]). The random-effects model performed better in predicting high-risk patients with TI than the classical logistic model (P value < .001). Our study showed a high TI score in patients followed in cardiology in Burkina Faso. Reduction of the TI score through targeted interventions is necessary to better control hypertension in our cohort patients.